Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$504M |
| 2 |
Cigna
CI
|
+$469M |
| 3 |
Intuitive Surgical
ISRG
|
+$392M |
| 4 |
Procter & Gamble
PG
|
+$387M |
| 5 |
Parker-Hannifin
PH
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$357M |
| 2 |
Adeia
ADEA
|
+$356M |
| 3 |
Target
TGT
|
+$346M |
| 4 |
Salesforce
CRM
|
+$344M |
| 5 |
Eli Lilly
LLY
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 12.51% |
| 3 | Financials | 11.68% |
| 4 | Industrials | 8.82% |
| 5 | Consumer Discretionary | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
MacroGenics
MGNX
$233M
| $89K | ﹤0.01% |
+13,268
| New | +$72.8K |
|
|
CHMI
3752
Cherry Hill Mortgage Investment Corp
CHMI
$82.3M
| $88K | ﹤0.01% |
15,233
+839
| +6% | +$4.71K |
|
3753
CleanSpark
CLSK
$3.08B
| $88K | ﹤0.01% |
42,905
-23,515
| -35% | -$60.9K |
|
3754
Harmony Gold Mining
HMY
$9.7B
| $87K | ﹤0.01% |
25,659
+1,147
| +5% | +$3.62K |
|
3755
Rackspace Technology
RXT
$960M
| $87K | ﹤0.01% |
29,330
-233
| -0.8% | -$984 |
|
3756
QuantumScape Corp
QS
$3.05B
| $86K | ﹤0.01% |
15,216
+4,442
| +41% | +$32.9K |
|
3757
Ocular Therapeutix
OCUL
$1.83B
| $85K | ﹤0.01% |
30,400
-11,058
| -27% | -$36.6K |
|
3758
Holley
HLLY
$335M
| $84K | ﹤0.01% |
+39,590
| New | +$125K |
|
3759
Nkarta
NKTX
$152M
| $84K | ﹤0.01% |
14,078
-69
| -0.5% | -$696 |
|
|
TEAD
3760
Teads Holding Co
TEAD
$76.2M
| $84K | ﹤0.01% |
23,100
-11,400
| -33% | -$44.6K |
|
3761
Fastly Inc
FSLY
$3.24B
| $83K | ﹤0.01% |
10,200
-11,278
| -53% | -$98.8K |
|
3762
Garrett Motion
GTX
$5.39B
| $83K | ﹤0.01% |
10,985
-334
| -3% | -$2.35K |
|
|
SRNE
3763
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $82K | ﹤0.01% |
92,656
-3,851
| -4% | -$5.11K |
|
3764
Rush Street Interactive
RSI
$3.17B
| $80K | ﹤0.01% |
22,227
-200
| -0.9% | -$742 |
|
3765
Gerdau
GGB
$9.54B
| $79K | ﹤0.01% |
+17,920
| New | +$77.1K |
|
3766
CorMedix
CRMD
$564M
| $75K | ﹤0.01% |
17,800
-9,700
| -35% | -$34.3K |
|
|
TBHC
3767
DELISTED
The Brand House Collective
TBHC
| $74K | ﹤0.01% |
22,300
-25,290
| -53% | -$93.1K |
|
|
CONN
3768
DELISTED
Conn's Inc.
CONN
| $74K | ﹤0.01% |
10,760
-51,759
| -83% | -$409K |
|
|
CMLS
3769
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $74K | ﹤0.01% |
11,964
+1,315
| +12% | +$9.4K |
|
|
CBAY
3770
DELISTED
Cymabay Therapeutics
CBAY
| $73K | ﹤0.01% |
11,561
-6,950
| -38% | -$26.4K |
|
3771
MeiraGTx Holdings
MGTX
$1.08B
| $72K | ﹤0.01% |
11,100
-1,605
| -13% | -$11K |
|
|
TEI
3772
Templeton Emerging Markets Income Fund
TEI
$310M
| $71K | ﹤0.01% |
12,912
-99,867
| -89% | -$480K |
|
|
NKLA
3773
DELISTED
Nikola Corporation Common Stock
NKLA
| $71K | ﹤0.01% |
1,090
-173
| -14% | -$14.5K |
|
|
SCWX
3774
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $67K | ﹤0.01% |
10,470
-1,000
| -9% | -$7.05K |
|
3775
FuelCell Energy
FCEL
$1.45B
| $62K | ﹤0.01% |
747
-46
| -6% | -$4.43K |
|
Similar funds
Ameriprise's Q4 2022 Portfolio in Review
As of Q4 2022, Ameriprise held 4,135 positions worth $292B, up 7.9% from $270B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Ameriprise's Q4 2022 filing shows 152 new, 1,522 increased, 2,111 reduced and 185 closed positions. Its largest new stake was Abcam PLC: 5,014,378 shares worth $78M. The largest sale was CVS Health, an estimated $357M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q4 2022 buy was Abcam PLC: 5,014,378 shares worth $78M.
- Ameriprise added most to Prologis in Q4 2022, an estimated $504M increase.
- Ameriprise's biggest Q4 2022 reduction was CVS Health, cutting an estimated $357M.
- Ameriprise fully exited Duke Realty Corp. in Q4 2022, selling an estimated $166M.
- Ameriprise's ten largest holdings make up 13% of its $292B portfolio in Q4 2022.
- Ameriprise opened 152 new positions and closed 185 in Q4 2022.
- Ameriprise's portfolio value rose 7.9% quarter-over-quarter to $292B.
Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.